IRADIMED CORP (IRMD) Stock Fundamental Analysis
NASDAQ:IRMD - US46266A1097 - Common Stock
72.69 USD
+1.19 (+1.66%)
72.69 USD
0 (0%)
IRMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. IRMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IRMD has a decent growth rate and is not valued too expensively. With these ratings, IRMD could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year IRMD was profitable.
IRMD had a positive operating cash flow in the past year.
IRMD had positive earnings in each of the past 5 years.
In the past 5 years IRMD always reported a positive cash flow from operatings.
1.2 Ratios
IRMD has a better Return On Assets (19.41%) than 97.84% of its industry peers.
IRMD's Return On Equity of 21.91% is amongst the best of the industry. IRMD outperforms 93.51% of its industry peers.
IRMD has a Return On Invested Capital of 19.30%. This is amongst the best in the industry. IRMD outperforms 97.30% of its industry peers.
IRMD had an Average Return On Invested Capital over the past 3 years of 18.78%. This is significantly above the industry average of 8.44%.
The 3 year average ROIC (18.78%) for IRMD is below the current ROIC(19.30%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.41% | ||
| ROE | 21.91% | ||
| ROIC | 19.3% |
ROA(3y)17.74%
ROA(5y)13.28%
ROE(3y)21.21%
ROE(5y)15.76%
ROIC(3y)18.78%
ROIC(5y)N/A
1.3 Margins
IRMD has a better Profit Margin (26.61%) than 94.59% of its industry peers.
In the last couple of years the Profit Margin of IRMD has remained more or less at the same level.
IRMD's Operating Margin of 30.67% is amongst the best of the industry. IRMD outperforms 97.30% of its industry peers.
In the last couple of years the Operating Margin of IRMD has grown nicely.
The Gross Margin of IRMD (76.96%) is better than 89.73% of its industry peers.
In the last couple of years the Gross Margin of IRMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.67% | ||
| PM (TTM) | 26.61% | ||
| GM | 76.96% |
OM growth 3Y8.49%
OM growth 5Y5.96%
PM growth 3Y5.58%
PM growth 5Y0.99%
GM growth 3Y0.12%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
IRMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for IRMD has been increased compared to 1 year ago.
Compared to 5 years ago, IRMD has more shares outstanding
There is no outstanding debt for IRMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 47.99 indicates that IRMD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 47.99, IRMD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for IRMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 47.99 |
ROIC/WACC2.16
WACC8.92%
2.3 Liquidity
A Current Ratio of 8.78 indicates that IRMD has no problem at all paying its short term obligations.
IRMD has a better Current ratio (8.78) than 90.27% of its industry peers.
IRMD has a Quick Ratio of 7.51. This indicates that IRMD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.51, IRMD belongs to the best of the industry, outperforming 90.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.78 | ||
| Quick Ratio | 7.51 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.25% over the past year.
IRMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.92% yearly.
Looking at the last year, IRMD shows a quite strong growth in Revenue. The Revenue has grown by 11.74% in the last year.
The Revenue has been growing by 13.71% on average over the past years. This is quite good.
EPS 1Y (TTM)11.25%
EPS 3Y25.74%
EPS 5Y13.92%
EPS Q2Q%16.67%
Revenue 1Y (TTM)11.74%
Revenue growth 3Y20.55%
Revenue growth 5Y13.71%
Sales Q2Q%13.84%
3.2 Future
IRMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.71% yearly.
Based on estimates for the next years, IRMD will show a quite strong growth in Revenue. The Revenue will grow by 11.12% on average per year.
EPS Next Y14.36%
EPS Next 2Y12.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.87%
Revenue Next 2Y11.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 40.84 indicates a quite expensive valuation of IRMD.
Based on the Price/Earnings ratio, IRMD is valued a bit cheaper than 70.81% of the companies in the same industry.
When comparing the Price/Earnings ratio of IRMD to the average of the S&P500 Index (27.03), we can say IRMD is valued expensively.
A Price/Forward Earnings ratio of 34.68 indicates a quite expensive valuation of IRMD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 70.27% of the companies listed in the same industry.
IRMD is valuated expensively when we compare the Price/Forward Earnings ratio to 22.63, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.84 | ||
| Fwd PE | 34.68 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 69.73% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 71.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 69.35 | ||
| EV/EBITDA | 34.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IRMD does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of IRMD may justify a higher PE ratio.
IRMD's earnings are expected to grow with 12.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.84
PEG (5Y)2.93
EPS Next 2Y12.71%
EPS Next 3YN/A
5. Dividend
5.1 Amount
IRMD has a yearly dividend return of 0.94%, which is pretty low.
IRMD's Dividend Yield is rather good when compared to the industry average which is at 1.74. IRMD pays more dividend than 92.97% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, IRMD's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
5.2 History
IRMD has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IRMD pays out 39.33% of its income as dividend. This is a sustainable payout ratio.
DP39.33%
EPS Next 2Y12.71%
EPS Next 3YN/A
72.69
+1.19 (+1.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners58.46%
Inst Owner Change1.21%
Ins Owners36.83%
Ins Owner Change0.67%
Market Cap924.62M
Analysts82.5
Price Target74.97 (3.14%)
Short Float %2.64%
Short Ratio3.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP39.33%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.43%
Min EPS beat(2)0.43%
Max EPS beat(2)10.44%
EPS beat(4)3
Avg EPS beat(4)4.6%
Min EPS beat(4)-1.96%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)6.12%
EPS beat(12)10
Avg EPS beat(12)7.27%
EPS beat(16)14
Avg EPS beat(16)11.73%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.05%
Max Revenue beat(2)0.01%
Revenue beat(4)1
Avg Revenue beat(4)-0.62%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)0.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.43%
Revenue beat(12)5
Avg Revenue beat(12)-0.16%
Revenue beat(16)7
Avg Revenue beat(16)-0.07%
PT rev (1m)3.52%
PT rev (3m)3.52%
EPS NQ rev (1m)5.75%
EPS NQ rev (3m)5.75%
EPS NY rev (1m)6.63%
EPS NY rev (3m)6.63%
Revenue NQ rev (1m)3.77%
Revenue NQ rev (3m)2.98%
Revenue NY rev (1m)2.84%
Revenue NY rev (3m)2.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.84 | ||
| Fwd PE | 34.68 | ||
| P/S | 11.91 | ||
| P/FCF | 69.35 | ||
| P/OCF | 34.07 | ||
| P/B | 9.8 | ||
| P/tB | 10.17 | ||
| EV/EBITDA | 34.81 |
EPS(TTM)1.78
EY2.45%
EPS(NY)2.1
Fwd EY2.88%
FCF(TTM)1.05
FCFY1.44%
OCF(TTM)2.13
OCFY2.94%
SpS6.1
BVpS7.41
TBVpS7.15
PEG (NY)2.84
PEG (5Y)2.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.41% | ||
| ROE | 21.91% | ||
| ROCE | 24.39% | ||
| ROIC | 19.3% | ||
| ROICexc | 42.22% | ||
| ROICexgc | 45.68% | ||
| OM | 30.67% | ||
| PM (TTM) | 26.61% | ||
| GM | 76.96% | ||
| FCFM | 17.17% |
ROA(3y)17.74%
ROA(5y)13.28%
ROE(3y)21.21%
ROE(5y)15.76%
ROIC(3y)18.78%
ROIC(5y)N/A
ROICexc(3y)57.41%
ROICexc(5y)N/A
ROICexgc(3y)63.62%
ROICexgc(5y)N/A
ROCE(3y)23.73%
ROCE(5y)N/A
ROICexcg growth 3Y-6.9%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-6.89%
ROICexc growth 5Y-0.24%
OM growth 3Y8.49%
OM growth 5Y5.96%
PM growth 3Y5.58%
PM growth 5Y0.99%
GM growth 3Y0.12%
GM growth 5Y-0.04%
F-Score4
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 1738.97% | ||
| Cap/Sales | 17.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 110.32% | ||
| Profit Quality | 64.54% | ||
| Current Ratio | 8.78 | ||
| Quick Ratio | 7.51 | ||
| Altman-Z | 47.99 |
F-Score4
WACC8.92%
ROIC/WACC2.16
Cap/Depr(3y)801.75%
Cap/Depr(5y)501.1%
Cap/Sales(3y)9.26%
Cap/Sales(5y)6.31%
Profit Quality(3y)60.91%
Profit Quality(5y)134.72%
High Growth Momentum
Growth
EPS 1Y (TTM)11.25%
EPS 3Y25.74%
EPS 5Y13.92%
EPS Q2Q%16.67%
EPS Next Y14.36%
EPS Next 2Y12.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.74%
Revenue growth 3Y20.55%
Revenue growth 5Y13.71%
Sales Q2Q%13.84%
Revenue Next Year11.87%
Revenue Next 2Y11.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.02%
EBIT growth 3Y30.78%
EBIT growth 5Y20.49%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.2%
FCF growth 3Y16.9%
FCF growth 5Y11.53%
OCF growth 1Y79.39%
OCF growth 3Y31.53%
OCF growth 5Y20.16%